承担国家自然科学基金2项，省级科研项目1项。
发表论文四十余篇，主要有：
[1] Li, Zhe-Hai; Hu, He; Zhang, Xiao-Yan; Liu, Guo-Dong; Ran, Bo; Zhang, Pei-Guang; Liao, Ming-Mei; Wu, Yu-Chi*. MiR-291a-3p regulates the BMSCs differentiation via targeting DKK1 in dexamethasone-induced osteoporosis.The Kaohsiung Journal of Medical Sciences. 2020, 36(1): 35-42.
[2] Duan B, Liu Y, Hu H, Shi FG, Liu YL, Xue H, Yun XY, Yan MY, Han XR, Chen AF, Wang Y, Li ZH *. Notch1-ADAM8 positive feed-back loop regulates the degradation of chondrogenic extracellular matrix and osteoarthritis progression. Cell Commun Signal. 2019;17:134.
[3] He Hu, Chuanlong Zhao , Peiguang Zhang , Yalong Liud, Yulian Jiang, Enquan Wu, Hao Xue , Caiyun Liu , Zhehai Li *.miR-26b modulates OA induced BMSC osteogenesis through regulating GSK3β/β-catenin pathway. Experimental and Molecular Pathology. 2019;107:158-164.
[4] He Hu,Zhehai Li(共同第一作者）,Min Lu,Xinyi Yun,Wei Li,Caiyun Liu, Ai Gu.Osteoactivin inhibits dexamethasone-induced osteoporosis through upregulating integrin β1 and activate ERK pathway.Biomedicine & Pharmacotherapy,2018，105：66-72.
[5] Zhehai Li, Qiande Liao, Yuchi Wu, Mingmei Liao,Yuqin Hao, Shengbin Zhang, Shipeng Song, Bing Li, Yang-de Zhang. Upregulation of a disintegrin and metalloprotease 8 influences tumor metastasis and prognosis in patients with osteosarcoma. Pathology & Oncology Research,2012,18(3):657-661.
[6] 李哲海,张霄雁,张飞等.骨-骨膜原位翻转修复髌软骨软化症的中长期疗效[J].中华骨科杂志,2011,31(11):1266-1271.
[7] 李哲海,张霄雁,刘国栋等.rAd-DKK1-shRNA表达载体的构建[J].中华生物医学工程杂志,2013,19(5):371-376.
